KYMR logo

Kymera Therapeutics (KYMR) Shareholders equity

annual shareholders equity:

$835.62M+$440.65M(+111.56%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual stockholders equity is $835.62 million, with the most recent change of +$440.65 million (+111.56%) on December 31, 2024.
  • During the last 3 years, KYMR annual shareholders equity has risen by +$375.98 million (+81.80%).
  • KYMR annual shareholders equity is now at all-time high.

Performance

KYMR Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

quarterly shareholders equity:

$786.23M-$49.39M(-5.91%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly stockholders equity is $786.23 million, with the most recent change of -$49.39 million (-5.91%) on March 31, 2025.
  • Over the past year, KYMR quarterly shareholders equity has increased by +$75.03 million (+10.55%).
  • KYMR quarterly shareholders equity is now -11.95% below its all-time high of $892.93 million, reached on September 30, 2024.

Performance

KYMR quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KYMR Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+111.6%+10.6%
3 y3 years+81.8%+83.4%
5 y5 years+1223.0%-

KYMR Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+111.6%-11.9%+99.1%
5 y5-yearat high+1223.0%-11.9%+655.7%
alltimeall timeat high+1223.0%-11.9%+1156.7%

KYMR Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$786.23M(-5.9%)
Dec 2024
$835.62M(+111.6%)
$835.62M(-6.4%)
Sep 2024
-
$892.93M(+30.4%)
Jun 2024
-
$684.92M(-3.7%)
Mar 2024
-
$711.20M(+80.1%)
Dec 2023
$394.97M(-19.4%)
$394.97M(-0.1%)
Sep 2023
-
$395.54M(-9.2%)
Jun 2023
-
$435.43M(-5.8%)
Mar 2023
-
$462.00M(-5.7%)
Dec 2022
$490.15M
$490.15M(-4.4%)
Sep 2022
-
$512.88M(+28.9%)
DateAnnualQuarterly
Jun 2022
-
$397.95M(-7.2%)
Mar 2022
-
$428.72M(-6.7%)
Dec 2021
$459.64M(+61.9%)
$459.64M(-4.9%)
Sep 2021
-
$483.13M(+87.2%)
Jun 2021
-
$258.10M(-6.2%)
Mar 2021
-
$275.25M(-3.0%)
Dec 2020
$283.89M(-481.5%)
$283.89M(-3.7%)
Sep 2020
-
$294.69M(+183.2%)
Jun 2020
-
$104.04M(-239.8%)
Dec 2019
-$74.41M(+116.1%)
-$74.41M
Dec 2018
-$34.44M
-

FAQ

  • What is Kymera Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Kymera Therapeutics?
  • What is Kymera Therapeutics annual shareholders equity year-on-year change?
  • What is Kymera Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly shareholders equity year-on-year change?

What is Kymera Therapeutics annual stockholders equity?

The current annual shareholders equity of KYMR is $835.62M

What is the all time high annual shareholders equity for Kymera Therapeutics?

Kymera Therapeutics all-time high annual stockholders equity is $835.62M

What is Kymera Therapeutics annual shareholders equity year-on-year change?

Over the past year, KYMR annual stockholders equity has changed by +$440.65M (+111.56%)

What is Kymera Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of KYMR is $786.23M

What is the all time high quarterly shareholders equity for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly stockholders equity is $892.93M

What is Kymera Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, KYMR quarterly stockholders equity has changed by +$75.03M (+10.55%)
On this page